scPharmaceuticals Statistics
Total Valuation
SCPH has a market cap or net worth of $159.36 million. The enterprise value is $141.72 million.
| Market Cap | 159.36M |
| Enterprise Value | 141.72M |
Important Dates
The next estimated earnings date is Thursday, August 8, 2024, after market close.
| Earnings Date | Aug 8, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
SCPH has 36.05 million shares outstanding. The number of shares has increased by 3.05% in one year.
| Shares Outstanding | 36.05M |
| Shares Change (YoY) | +3.05% |
| Shares Change (QoQ) | +0.42% |
| Owned by Insiders (%) | 11.65% |
| Owned by Institutions (%) | 76.92% |
| Float | 16.11M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 9.04 |
| Forward PS | 3.20 |
| PB Ratio | 6.49 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 8.04 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.21, with a Debt / Equity ratio of 1.66.
| Current Ratio | 6.21 |
| Quick Ratio | 5.21 |
| Debt / Equity | 1.66 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -5.98 |
Financial Efficiency
Return on equity (ROE) is -132.40% and return on invested capital (ROIC) is -91.33%.
| Return on Equity (ROE) | -132.40% |
| Return on Assets (ROA) | -58.70% |
| Return on Capital (ROIC) | -91.33% |
| Revenue Per Employee | $129,647 |
| Profits Per Employee | -$424,324 |
| Employee Count | 136 |
| Asset Turnover | 0.18 |
| Inventory Turnover | 0.76 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -47.07% in the last 52 weeks. The beta is 0.10, so SCPH's price volatility has been lower than the market average.
| Beta (5Y) | 0.10 |
| 52-Week Price Change | -47.07% |
| 50-Day Moving Average | 4.23 |
| 200-Day Moving Average | 5.18 |
| Relative Strength Index (RSI) | 50.71 |
| Average Volume (20 Days) | 180,249 |
Short Selling Information
The latest short interest is 5.83 million, so 16.17% of the outstanding shares have been sold short.
| Short Interest | 5.83M |
| Short Previous Month | 5.78M |
| Short % of Shares Out | 16.17% |
| Short % of Float | 36.19% |
| Short Ratio (days to cover) | 24.04 |
Income Statement
In the last 12 months, SCPH had revenue of $17.63 million and -$57.71 million in losses. Loss per share was -$1.48.
| Revenue | 17.63M |
| Gross Profit | 12.64M |
| Operating Income | -59.70M |
| Pretax Income | -57.71M |
| Net Income | -57.71M |
| EBITDA | -48.87M |
| EBIT | -49.45M |
| Loss Per Share | -$1.48 |
Balance Sheet
The company has $58.45 million in cash and $40.80 million in debt, giving a net cash position of $17.65 million or $0.49 per share.
| Cash & Cash Equivalents | 58.45M |
| Total Debt | 40.80M |
| Net Cash | 17.65M |
| Net Cash Per Share | $0.49 |
| Equity (Book Value) | 24.57M |
| Book Value Per Share | 0.68 |
| Working Capital | 64.21M |
Cash Flow
In the last 12 months, operating cash flow was -$60.45 million and capital expenditures -$40,000, giving a free cash flow of -$60.49 million.
| Operating Cash Flow | -60.45M |
| Capital Expenditures | -40,000 |
| Free Cash Flow | -60.49M |
| FCF Per Share | -$1.55 |
Margins
Gross margin is 71.69%, with operating and profit margins of -338.58% and -327.29%.
| Gross Margin | 71.69% |
| Operating Margin | -338.58% |
| Pretax Margin | -327.29% |
| Profit Margin | -327.29% |
| EBITDA Margin | -277.18% |
| EBIT Margin | -280.43% |
| FCF Margin | -343.08% |
Dividends & Yields
SCPH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.05% |
| Shareholder Yield | -3.05% |
| Earnings Yield | -36.21% |
| FCF Yield | -37.96% |
Analyst Forecast
The average price target for SCPH is $19.00, which is 329.86% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $19.00 |
| Price Target Difference | 329.86% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | 89.75% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SCPH has an Altman Z-Score of -4.37 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -4.37 |
| Piotroski F-Score | 2 |